"Semustine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
Descriptor ID |
D012673
|
MeSH Number(s) |
D02.654.692.440.700 D02.948.594.440.700
|
Concept/Terms |
Semustine- Semustine
- MeCCNU
- Methyl-CCNU
- Methyl CCNU
- Me-CCNU
- Me CCNU
|
Below are MeSH descriptors whose meaning is more general than "Semustine".
Below are MeSH descriptors whose meaning is more specific than "Semustine".
This graph shows the total number of publications written about "Semustine" by people in this website by year, and whether "Semustine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Semustine" by people in Profiles.
-
In vivo drug sensitivity assay of clonogenic human melanoma cells and correlation with treatment outcome. Cancer Res. 1983 Jul; 43(7):3434-40.
-
Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Cancer Treat Rep. 1982 Aug; 66(8):1613-7.
-
Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea. Am J Clin Oncol. 1982 Aug; 5(4):421-7.